尼奥尼科丁类药物会破坏蜜蜂的飞行,生物能平衡和神经传递
Zepu Gao1, Lin Ji2, Wennan Luo1
1College of Science, China Agricultural University, Beijing 100193, China; CAU-East Mab Joint Laboratory for Intelligent Screening and Creation of Active Molecules, China Agricultural University, Beijing 100093, China.
Journal of hazardous materials
|February 28, 2026
概括
诸如伊米达克洛普里德 (imidacloprid) 和弗鲁皮拉迪龙 (flupyradifurone) 这样的类农药会导致蜜蜂和过度活跃. 伊米达克洛普里德更有毒,通过破坏能量和神经递质,影响蜜蜂的生存和飞行.
科学领域:
- 行为生态学 行为生态学
- 农药毒理学 农药毒理学
- 人工智能在生物学中的应用
背景情况:
- 蜜蜂数量下降威胁着生物多样性和粮食安全,新类杀虫剂被认为是主要的压力因素.
- 了解蜜蜂中农药诱导的行为障碍的神经和生理基础至关重要,但由于它们的小尺寸和社会行为,具有挑战性.
- 现有的风险评估方法与动态环境和单个蜜蜂行为跟踪作斗争.
研究的目的:
- 开发一种基于人工智能的系统,用于自动化,高分辨率地跟踪单个蜜蜂的行为.
- 为了分析由新烟类农药伊米达克洛普里德和flupyradifurone引起的特定的行为异常.
- 为了比较imidacloprid和flupyradifurone对蜜蜂的毒性和神经生物学影响.
主要方法:
- 介绍了TCA-YOLOv7,一种没有人工智能标记的全景跟踪系统,采用了增强的YOLOv7架构,具有交叉注意力和旋转变压器模块.
- 实现一个多摄像头阵列,具有几何投影和特征匹配,用于精确的3D轨迹重建多个蜜蜂.
- 对行为,神经生物学和生物化学数据的分析,以评估农药对蜜蜂飞行,生存和生理功能的影响.
主要成果:
- TCA-YOLOv7实现了99.5%的检测准确度,减少了68.4%的跟踪误差,并达到亚毫米空间精度,优于传统模型.
- 蜜蜂接触到伊米达克洛普里德和弗鲁皮拉迪富隆,表现出明显的异常,包括和过度活跃,显著改变了飞行模式.
- 伊米达克洛普里德的毒性明显高于flupyradifurone,在低度 (40μg·L-1) 降低了生存和飞行能力,这两种农药都抑制了ATP的能量供应并破坏了神经递质的传输.
结论:
- TCA-YOLOv7系统为详细分析农药诱导的蜜蜂行为变化提供了一个强大的平台.
- 伊米达克洛普里德和flupyradifurone诱导显著的神经毒性作用,导致异常行为和蜜蜂的飞行能力降低.
- 与flupyradifurone相比,伊米达克洛普里德对蜜蜂的健康和生存构成更大的风险,这凸显了需要仔细监管类杀虫剂的必要性.
相关概念视频
Migration
Migration is long-range, seasonal movement from one region or habitat to another. This common strategy, carried out by many different organisms around the world, is an adaptive response that typically corresponds to changes in an organism’s environment, like resource availability or climate. Migrations can involve huge groups of thousands of animals as well as single individuals traveling alone and can range from thousands of kilometers to just a few hundred meters.
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...


